China has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...

U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...

Leading American genomic sequencing firm Illumina says it is evaluating Beijing’s announcement with hope of ‘positive ...

Think tanks and universities have helped expose problematic Chinese business practices. Now, those businesses are accusing ...

With Chinese firms becoming major players in drug development, the traditional balance of power in global pharmaceuticals is ...

Tommy Hilfiger and Calvin Klein owner PVH (PVH) and biotechnology company Illumina (ILMN) were among the first casualties on ...

A recent report from Stifel showed that 30% of licensing deals from big pharma companies now involve a Chinese biotech.

China announced on Tuesday the inclusion of two US enterprises - clothing company PVH Group and biotechnology company ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We get into more ...